Connect With Europe's Leading Tumour Modelling Decision Makers
The tumour modelling landscape is evolving rapidly as organisations seek more predictive, human-relevant, and translationally relevant approaches to support oncology drug development.
Attendees are actively evaluating new solutions across organoids, tumour-on-chip systems, patient-derived models, humanized models, imaging platforms, biomarker technologies, AI-driven analytics, and CRO partnerships.
Partnering with the 15th Tumour Models Summit London gives your organisation direct access to scientists, directors, VPs, CSOs and translational leaders actively seeking technologies and services that improve confidence in efficacy prediction, safety assessment, model validation and candidate progression decisions.
What to Expect?
Meet New Customers
Connect with preclinical, translational and pharmacology leaders actively seeking new modelling, biomarker and analytical solutions.
Generate High-Quality Business Opportunities
Build relationships with organisations actively investing in next-generation tumour models and translational technologies.
Demonstrate Your Expertise
Position your organisation as a scientific thought leader through presentations, interactive discussions and exhibition opportunities.
Gain Market Intelligence
Hear directly from industry leaders about current challenges, future priorities and purchasing needs across oncology model development.
Key Interest Areas
Our attendees are actively evaluating vendors, CROs and technology providers with expertise across:
- In Vitro Modelling CROs
- Ex Vivo / In Vivo Modelling CROs
- Humanized Mouse Models
- PDX Models (Patient-Derived Xenograft Models)
- Organoids & Tumour-on-Chip Systems
- Biomarker & Translational Analytics Platforms
- Bioprinting platforms
- AI & Computational Biology Platforms
- Imaging & High-Content Analysis Technologies
Hear What Our Past Sponsors Have to Say
There was a good conference layout, nice set-up of exhibitors around the food/drinks area, strong pharma/biotech speakers, and a nice range of session types e.g. small group discussions, fireside etc.
Champions Oncology
Good venue and good cross section of delegates!
Reaction Biology
Audience Composition
Attendees by Country
Attendee Seniority
Companies Attending Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us at sponsor@hansonwade.com if you would like to get involved and discuss a bespoke package suited to your needs.
Stay Ahead of Emerging Trends
Position your organisation alongside leaders shaping the future of tumour modelling.
Connect With Decision Makers
Meet senior scientists, translational leaders and executives evaluating new solutions.
Showcase Your Expertise
Demonstrate how your technologies improve model relevance, translatability and development success.